A Study of GENEVAX-HIV, a Possible Vaccine
NCT00002232
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
INDUSTRY
Sponsor class
Conditions
HIV Infections
HIV Seronegativity
Interventions
BIOLOGICAL:
APL 400-003
Sponsor
Wyeth-Lederle Vaccines